France legalises medically assisted dying for terminally ill after National Assembly vote
France legalises medically assisted dying for terminally ill as National Assembly approves; law outlines eligibility, safeguards and faces Constitutional review.
France’s lower house of parliament on Wednesday approved a historic bill legalising medically assisted dying for adults with terminal illnesses, marking a major change in the country’s approach to end-of-life care. The National Assembly backed the measure by 291 votes to 241, overcoming repeated resistance in the Senate and setting in motion a constitutional review that could determine the law’s final form. The new framework permits physicians to assist adults who meet strict criteria and establishes timelines and medical oversight intended to limit abuses. The vote caps more than two years of political and public debate over the scope and safeguards of assisted dying in France.
Parliamentary vote and political context
The National Assembly’s approval came after protracted negotiations between centrists, left-leaning deputies and conservative opponents in the upper house. Lawmakers in favour argued the bill safeguards personal autonomy for patients facing inexorable decline and intolerable suffering. Opponents in the Senate called for more protections and pointed to ethical and medical complications, leaving the final decision to the lower chamber’s majority. The vote follows a promise by President Emmanuel Macron to advance assisted dying legislation after his 2022 re-election pledge.
Eligibility and medical safeguards
Under the law, adults who are French citizens or live in France on a stable and regular basis may request medically assisted dying if they suffer from an incurable, life-limiting condition in an advanced or terminal stage. A treating physician and a specialist panel must review requests within 15 days to confirm eligibility and absence of viable alternatives to relieve suffering. If approved, the patient is required to observe a minimum waiting period of two days before proceeding with the decision. Patients must generally self-administer the lethal substance; only if they are physically unable may a doctor or nurse administer it on their behalf.
Procedural oversight and legal protections
The bill stipulates multi-step oversight to reduce the risk of error or coercion, including documented medical assessments and independent review by specialists. Physicians who participate will be protected from criminal liability when the procedure follows the statutory safeguards, while refusals by medical staff on conscience grounds remain respected. The legislation also preserves existing rights to refuse treatment and to withdraw life support, distinguishing assisted dying as a regulated option rather than a replacement for palliative care. Critics continue to press for clearer protocols on psychiatric evaluation, reporting obligations and end-of-life counselling.
Public reaction and demonstrations
Public opinion in France has shifted steadily in favour of assisted dying over recent decades, a change often traced to high-profile cases that focused national attention on suffering and autonomy. That shift has not been uniform: religious leaders, some medical professionals and civil society groups organised protests in Paris and other cities, with one rally last month drawing nearly 4,000 participants according to local reports. Advocates celebrated the vote as a humane expansion of patient rights, while opponents warned of societal risks and the potential for vulnerable people to feel pressured to end their lives prematurely. The debate has exposed deep ethical divisions across politics, faith communities and medical practice.
Senate objections and prominent dissent
Conservative figures in the Senate have repeatedly argued the bill lacks sufficient safeguards and could produce unintended consequences, framing their objections around both ethics and medical responsibility. The president of the Senate cautioned that the proposal had left many unresolved questions and described the divisions within the legislature as significant. Prominent public intellectuals and cultural figures voiced stark opposition in national media, arguing the law could have broader cultural implications. Supporters counter that careful regulation and oversight can reconcile individual liberty with medical ethics.
Constitutional Council review and next steps
Prime Minister Sébastien Lecornu signalled plans to refer the law to the Constitutional Council for review, a standard procedure in France for measures raising fundamental legal questions. The Council’s assessment will focus on compatibility with constitutional protections and may require amendments or clarifications before implementation. If the Council clears the measure, lawmakers and health authorities will need to draft implementing regulations and a reporting system for medical practice. Health ministries and professional bodies will be tasked with issuing clinical guidance and training to ensure consistent application across hospitals and care settings.
The passage of this law places France among a small group of countries that have legalised some forms of assisted dying, joining nations in Western Europe and several jurisdictions in North America. As the Constitutional Council prepares to examine the text, the political and ethical debate is likely to continue, with health practitioners, patient advocates and lawmakers watching closely for the practical and legal contours that will define how the new right is put into practice.